SCHEMBL7470085

SCHEMBL7470085

CCCCC1(CC)CSc2cc(OC)c(OC)cc2C(c2ccccc2)=N1

nearest known ligand 0.40

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC10A2 Q12908 3/20 0.33
MAPK10 P53779 2/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CHRM1 P11229 1/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
DPP4 P27487 1/20 0.32
GLA P06280 1/20 0.31
RCE1 Q9Y256 1/20 0.31
PDGFRB P09619 1/20 0.31
LMNA P02545 1/20 0.31
PDE4B Q07343 1/20 0.30
PDE4D Q08499 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7472192 1.00 SLC10A2 (0.33) SLC10A2MAPK10MAPK1TDP1CHRM1
SCHEMBL19170232 0.92 CDK4 (0.32) SLC10A2MAPK10
SCHEMBL2589094 0.89 MAOA (0.37) KDM4E
SCHEMBL2589232 0.89 SLC10A2 (0.33) SLC10A2KDM4EALDH1A1
SCHEMBL17506154 0.89 DRD2 (0.32) SLC10A2
SCHEMBL17506155 0.89 DRD2 (0.32) SLC10A2
SCHEMBL2585237 0.88 MAPK1 (0.32) MAPK10MAPK1TDP1CHRM1
SCHEMBL7469254 0.86 EGFR (0.40) SLC10A2CHRM1KDM4E
SCHEMBL7463854 0.86 EGFR (0.40) SLC10A2CHRM1KDM4E
SCHEMBL2589896 0.86 MAPK1 (0.35) SLC10A2MAPK1TDP1CHRM1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0775126-B1 HYPOLIPIDEMIC 1,4-BENZOTHIAZEPINE-1,1-DIOXIDES WELLCOME FOUND (GB) 2002-10-30 EP disclosed
EP-1203769-A1 Hypolipidemic 1,4-benzothiazepine derivative THE WELLCOME FOUNDATION LIMITED (GB) 2002-05-08 EP disclosed
CN-1059673-C Hypolipidemic 1, 4-benzazepine * -1, 1-dioxides WELLCOME FOUND (GB) 2000-12-20 CN disclosed
US-5910494-A NOVEL COMPOUNDS THAT REDUCE THE ABSORPTION OF BILE ACIDS FROM THE INTESTINE; FOR PROPHYLAXIS AND TREATMENT OF HYPERLIPIDEMIC CONDITIONS, SUCH AS ATHEROSCLEROSIS GLAXO WELLCOME INC. (US) 1999-06-08 US disclosed
CN-1161035-A Hypolipidemic 1,4-benzothiazepine-1,1-dioxides WELLCOME FOUND (GB) 1997-10-01 CN disclosed